Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Can Big Data Match Up To The Big Promise?

Executive Summary

Big data offers great promise for improving drug development and regulation, but a number of challenges need to be addressed, such as integrating datasets from disparate sources, ensuring the information can be used for the intended purpose, and balancing the interests of individual patients with wider societal benefits.

Advertisement

Related Content

Denmark Leads New EU Task Force Exploring Use Of Big Data In Medicines Assessment

Topics

Advertisement
UsernamePublicRestriction

Register

PS120447

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel